Therorna

Pioneering next-generation circular RNA medicines

Beijing, China · Founded 2021 · $42.0M raised

Headquarters
Beijing
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$42.0M
Last Round
$42.0M Series AJun 2022
Rounds
1

About

Therorna Inc. (圆因(北京)生物科技有限公司) is a Beijing-based biotech company founded in April 2021 by Wensheng Wei, a professor at the School of Life Sciences at Peking University, along with a team of leading domestic experts and senior overseas PhD returnees. The company specializes in circular RNA (circRNA) technology, developing an innovative pipeline of preventive and therapeutic drugs targeting unmet clinical needs including infectious diseases, cancer, and genetic disorders. Therorna has advanced clinical-ready programs in circular RNA-based in vivo CAR-T cell therapy and a broad circRNA vaccine and therapeutic pipeline, having raised a $42 million Series A in 2022 and presented at major international gene therapy conferences.

Summary

Therorna is a Biotech company based in Beijing, China, founded in 2021. It has raised $42.0M in total across 1 round, most recently a $42.0M Series A round in Jun 2022. Investors include MSA Capital, Sherpa Healthcare Partners and Quan Capital.

Tech & App Stack

1 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2022
$42.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Therorna on Indexed.vc
<a href="https://indexed.vc/companies/therorna"><img src="https://indexed.vc/api/badge/company/therorna" alt="Therorna on Indexed.vc" width="260" height="76" /></a>